高密度リポタンパク質が,アテロゲンなプロセスを遅らせるメカニズムです
Lancet (London, England)
|June 19, 1976
まとめ
高密度脂質タンパク質 (HDL) は,動脈細胞におけるコレステロールの蓄積を防止することによって,動脈硬化から保護する可能性があります. HDLは低密度リポプロテイン (LDL) の吸収と蓄積を減少させ,そのアテロプロテクト効果のための潜在的なメカニズムを提供します.
科学分野:
- 心血管生物学 心血管生物学
- 脂質代謝 脂質代謝とは
- 動脈硬化症の研究 動脈硬化症の研究
背景:
- 高密度リポプロテイン (HDL) 血レベルと動脈硬化症のリスクの間には負の相関が存在します.
- HDLはコレステロールの細胞外輸送を促進すると考えられており,動脈硬化症を予防する重要な要因です.
研究 の 目的:
- 動脈の滑らかな筋肉細胞におけるHDLと低密度リポプロテイン (LDL) の相互作用を調査する.
- HDLがアテロ保護効果を発揮する第二のメカニズムを探求する.
主な方法:
- 豚の動脈の滑らかな筋肉細胞におけるリポプロテイン代謝を研究した.
- これらの細胞によるHDLとLDLの吸収,内部化,分解を比較した.
- LDL誘発の細胞コレステロール蓄積に対するHDLの影響を評価した.
主要な成果:
- HDLは,LDLと同様,滑らかな筋肉細胞と結合するが,内化され,よりゆっくりと分解される.
- LDLをインキュベートした細胞はコレステロールの増加を示したが,HDLをインキュベートした細胞はコレステロールの増加を示さなかった.
- HDLは,LDLの吸収と分解を部分的に抑制し,LDL誘発の細胞コレステロールの蓄積を抑制しました.
結論:
- 細胞レベルでLDLとHDLの相互作用は,動脈硬化に対する保護的役割に貢献する潜在的なメカニズムを表しています.
- この細胞相互作用は,プラズマのHDL濃度と動脈硬化リスクの間の観察された逆関係を説明する可能性がある.
関連する概念動画
01:38Inflammation
Overview
01:31Lipid-derived Compounds in the Human Body
Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin, delayed...
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin, delayed...
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:29Cholesterol: Significance and Regulation
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
01:30Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...